That reputation is true as far as its goes. But, in spite of the emphasis on pure science, Yeda Research and Development, Weizmann’s technology transfer arm, has had great success in its efforts to ...

announced a license and research collaboration agreement with Dr. Nir London and the Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science ...

REHOVOT, Israel--(BUSINESS WIRE)--flō has signed an exclusive license agreement with Yeda Research and Development Co., Ltd. regarding the use of Weizmann Advanced Materials used for optical ...

YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company ...

About Yeda Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda currently manages approximately 500 unique patent families and has generated ...

DURHAM, N.C., Nov. 17, 2021 (GLOBE NEWSWIRE) -- CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies ...

"We are happy to collaborate with the Weizmann Institute of Science, through its commercial arm, Yeda, on Myeloid research using Sequentify's Myeloid panel for the research of CKD and cognitive ...

The Weizmann Institute has been working with Steba researchers for some 20 years to develop Tookad, said Amir Naiberg, CEO of the Yeda Research and Development Company, the Weizmann Institute’s ...